Jennifer Lovick, Executive Editor of Technology in Cancer Research and Treatment and Gold Open Access Biomedical Journals, shared a post on LinkedIn:
“Explore the latest research from Technology in Cancer Research and Treatment’s October round-up, featuring in-depth studies and reviews.
See all articles published in October.
Featured articles of the month:
Clinical Potential of Copy Number Aberration as a Diagnostic and Prognostic Biomarker in Lymphoma
This review highlights how copy number aberrations (CNAs) are emerging as key biomarkers for lymphoma diagnosis and prognosis, with new technologies improving detection and clinical translation.
A Retrospective Comparison of CT Imaging and Computational Simulations of Irreversible Electroporation in the Liver
This study compares CT imaging and computer simulations for liver tumor ablation, validating simulation accuracy and highlighting the importance of timely imaging in IRE procedures.
Dosimetric and Geometric Analysis for MLC Based and Iris Based Treatment Plans: A Retrospective Study for Intracranial Tumors with Cyberknife Device
This study compares MLC and Iris collimators in Cyberknife radiosurgery, showing MLC plans offer efficient, centralized high-dose delivery, while Iris excels near critical structures.
Comparative Evaluation of Wavelength-Dependent Photodynamic Therapy Efficacy Using Representative Red and Near-Infrared Photosensitizers in a Single Tumor Model
This study finds red and near-infrared PDT have equivalent efficacy in tumor models, supporting flexible photosensitizer selection for future cancer therapies.
Equivalent-Uniform-Dose Optimization for Spatially Fractionated Radiation Therapy
This research introduces EUD optimization for SFRT, reducing dose and increasing survival fraction, advancing precision in radiotherapy planning.
Feasibility Study of Using Post-Contrast ED Maps Synthesized from Spectral Computed Tomography for Photon Radiotherapy Treatment Planning in Pelvic Tumors
This study shows ED maps from spectral CT minimize dose calculation errors from contrast agents, improving radiotherapy planning efficiency for pelvic tumors.”
More posts featuring Jennifer Lovick.